Cargando…

Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury

The cytokines IL-1α and IL-1β are induced rapidly after insults to the CNS, and their subsequent signaling through the type 1 IL-1 receptor (IL-1R1) has been regarded as essential for a normal astroglial and microglial/macrophage response. To determine whether abrogating signaling through the IL-1R1...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hsiao-Wen, Basu, Anirban, Druckman, Charles, Cicchese, Michael, Krady, J Kyle, Levison, Steven W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533808/
https://www.ncbi.nlm.nih.gov/pubmed/16808851
http://dx.doi.org/10.1186/1742-2094-3-15
_version_ 1782129062477561856
author Lin, Hsiao-Wen
Basu, Anirban
Druckman, Charles
Cicchese, Michael
Krady, J Kyle
Levison, Steven W
author_facet Lin, Hsiao-Wen
Basu, Anirban
Druckman, Charles
Cicchese, Michael
Krady, J Kyle
Levison, Steven W
author_sort Lin, Hsiao-Wen
collection PubMed
description The cytokines IL-1α and IL-1β are induced rapidly after insults to the CNS, and their subsequent signaling through the type 1 IL-1 receptor (IL-1R1) has been regarded as essential for a normal astroglial and microglial/macrophage response. To determine whether abrogating signaling through the IL-1R1 will alter the cardinal astrocytic responses to injury, we analyzed molecules characteristic of activated astrocytes in response to a penetrating stab wound in wild type mice and mice with a targeted deletion of IL-1R1. Here we show that after a stab wound injury, glial fibrillary acidic protein (GFAP) induction on a per cell basis is delayed in the IL-1R1-null mice compared to wild type counterparts. However, the induction of chondroitin sulfate proteoglycans, tenascin, S-100B as well as glutamate transporter proteins, GLAST and GLT-1, and glutamine synthetase are independent of IL-1RI signaling. Cumulatively, our studies on gliosis in the IL-1R1-null mice indicate that abrogating IL-1R1 signaling delays some responses of astroglial activation; however, many of the important neuroprotective adaptations of astrocytes to brain trauma are preserved. These data recommend the continued development of therapeutics to abrogate IL-1R1 signaling to treat traumatic brain injuries. However, astroglial scar related proteins were induced irrespective of blocking IL-1R1 signaling and thus, other therapeutic strategies will be required to inhibit glial scarring.
format Text
id pubmed-1533808
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15338082006-08-08 Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury Lin, Hsiao-Wen Basu, Anirban Druckman, Charles Cicchese, Michael Krady, J Kyle Levison, Steven W J Neuroinflammation Research The cytokines IL-1α and IL-1β are induced rapidly after insults to the CNS, and their subsequent signaling through the type 1 IL-1 receptor (IL-1R1) has been regarded as essential for a normal astroglial and microglial/macrophage response. To determine whether abrogating signaling through the IL-1R1 will alter the cardinal astrocytic responses to injury, we analyzed molecules characteristic of activated astrocytes in response to a penetrating stab wound in wild type mice and mice with a targeted deletion of IL-1R1. Here we show that after a stab wound injury, glial fibrillary acidic protein (GFAP) induction on a per cell basis is delayed in the IL-1R1-null mice compared to wild type counterparts. However, the induction of chondroitin sulfate proteoglycans, tenascin, S-100B as well as glutamate transporter proteins, GLAST and GLT-1, and glutamine synthetase are independent of IL-1RI signaling. Cumulatively, our studies on gliosis in the IL-1R1-null mice indicate that abrogating IL-1R1 signaling delays some responses of astroglial activation; however, many of the important neuroprotective adaptations of astrocytes to brain trauma are preserved. These data recommend the continued development of therapeutics to abrogate IL-1R1 signaling to treat traumatic brain injuries. However, astroglial scar related proteins were induced irrespective of blocking IL-1R1 signaling and thus, other therapeutic strategies will be required to inhibit glial scarring. BioMed Central 2006-06-30 /pmc/articles/PMC1533808/ /pubmed/16808851 http://dx.doi.org/10.1186/1742-2094-3-15 Text en Copyright © 2006 Lin et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Lin, Hsiao-Wen
Basu, Anirban
Druckman, Charles
Cicchese, Michael
Krady, J Kyle
Levison, Steven W
Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury
title Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury
title_full Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury
title_fullStr Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury
title_full_unstemmed Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury
title_short Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury
title_sort astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533808/
https://www.ncbi.nlm.nih.gov/pubmed/16808851
http://dx.doi.org/10.1186/1742-2094-3-15
work_keys_str_mv AT linhsiaowen astrogliosisisdelayedintype1interleukin1receptornullmicefollowingapenetratingbraininjury
AT basuanirban astrogliosisisdelayedintype1interleukin1receptornullmicefollowingapenetratingbraininjury
AT druckmancharles astrogliosisisdelayedintype1interleukin1receptornullmicefollowingapenetratingbraininjury
AT cicchesemichael astrogliosisisdelayedintype1interleukin1receptornullmicefollowingapenetratingbraininjury
AT kradyjkyle astrogliosisisdelayedintype1interleukin1receptornullmicefollowingapenetratingbraininjury
AT levisonstevenw astrogliosisisdelayedintype1interleukin1receptornullmicefollowingapenetratingbraininjury